remodel trial semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical The REMODEL Trial: Framework and

A tailored collagen routine with Pura Collagenis the perfect accompaniment to a transformational journey.

How to get enough protein, manage side effects, and structure your meals.

Combatting the opioid overdose epidemic has some good news emerging from the medicines sector, with per capita prescribing of opioids down 67% since its apex in 2011

Understanding this conversion is essential for safe dosing, but biomarkers and individual metabolic factors should inform whether this dose level is appropriate for your specific health profile

Jarrells (D-Columbus) and Majority Whip Josh Williams (R-Sylvania Twp.) today held a press conference introducing bipartisan legislation to reimburse state employees for out-of-pocket costs associated with GLP-1 drugs-medications commonly prescribed for chronic weight management and other metabolic conditions.